Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas F Nixon

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
Journal of Medical Virology|April 4, 2020
Comments on "coinfection of SARS-CoV-2 and HIV in a patient in Wuhan city, China"Douglas F Nixon
Nature Reviews. Molecular Cell Biology|October 23, 2023
Activation of human endogenous retroviruses and its physiological consequencesNicholas Dopkins, Douglas F Nixon
The Journal of Infectious Diseases|September 18, 2010
T cell immunity in acute HIV-1 infectionHendrik Streeck, Douglas F Nixon
Trends in Microbiology|September 24, 2022
Two-step recognition of HIV-1 DNA in the cytosolNicholas Dopkins, Douglas F Nixon
The Lancet. Infectious Diseases|January 31, 2009
Herpes simplex virus and HIV-1: deciphering viral synergyRex G Cheng, Douglas F Nixon
AIDS Research and Human Retroviruses|March 6, 2019
The Intimate Relationship Between CD4+ T Cell Morphology and HIV-1 InfectionRobert L Furler, Douglas F Nixon
Current Opinion in HIV and AIDS|April 18, 2009
Treatment interruption in chronic HIV-1 infection: does it deliver?Christian B Willberg, Douglas F Nixon
AIDS Research and Human Retroviruses|October 29, 2021
HIV-1 Exploits Transitions Between CD4<sup>+</sup> T Cell Migration and ActivationRobert L Furler, Douglas F Nixon
The New England Journal of Medicine|June 2, 2021
Vaccine Breakthrough Infections with SARS-CoV-2 VariantsDouglas F Nixon, Lishomwa C Ndhlovu
Human Vaccines & Immunotherapeutics|February 5, 2021
Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from GermanyDaniela Marín-Hernández, Douglas F Nixon, Nathaniel Hupert
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
Journal of Medical Virology|April 4, 2020
Comments on "coinfection of SARS-CoV-2 and HIV in a patient in Wuhan city, China"Douglas F Nixon
Nature Reviews. Molecular Cell Biology|October 23, 2023
Activation of human endogenous retroviruses and its physiological consequencesNicholas Dopkins, Douglas F Nixon
The Journal of Infectious Diseases|September 18, 2010
T cell immunity in acute HIV-1 infectionHendrik Streeck, Douglas F Nixon
Trends in Microbiology|September 24, 2022
Two-step recognition of HIV-1 DNA in the cytosolNicholas Dopkins, Douglas F Nixon
The Lancet. Infectious Diseases|January 31, 2009
Herpes simplex virus and HIV-1: deciphering viral synergyRex G Cheng, Douglas F Nixon
AIDS Research and Human Retroviruses|March 6, 2019
The Intimate Relationship Between CD4+ T Cell Morphology and HIV-1 InfectionRobert L Furler, Douglas F Nixon
Current Opinion in HIV and AIDS|April 18, 2009
Treatment interruption in chronic HIV-1 infection: does it deliver?Christian B Willberg, Douglas F Nixon
AIDS Research and Human Retroviruses|October 29, 2021
HIV-1 Exploits Transitions Between CD4<sup>+</sup> T Cell Migration and ActivationRobert L Furler, Douglas F Nixon
The New England Journal of Medicine|June 2, 2021
Vaccine Breakthrough Infections with SARS-CoV-2 VariantsDouglas F Nixon, Lishomwa C Ndhlovu
Human Vaccines & Immunotherapeutics|February 5, 2021
Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from GermanyDaniela Marín-Hernández, Douglas F Nixon, Nathaniel Hupert
Pageof 26